Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Recipient : Hershey Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparing OTC Acne Treatment to Prescription Regimen
Details : BenzaClin is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 10, 2010
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Recipient : Hershey Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable